Regeneron CEO on 23andMe & $275m in Margaritaville 6/11/25

The U.S. and China have reached a framework for a trade deal, marking progress in the London talks between both nations. Bankrupt 23andMe is up for sale, and drugmaker Regeneron is at the negotiating table. CEO Dr. Len Schleifer discusses the value of genetic data in medicine, explaining the role DNA plays in developing drug therapies. Plus, Elon Musk has posted an X of regret after publicly clashing with President Trump on social media, and CNBC’s Robert Frank reports on Jimmy Buffett’s $275 million estate, currently caught between the Margaritaville empire’s two trustees. Dr. Len Schleifer - 14:18 Robert Frank - 29:14 In this episode: Robert Frank, @robtfrank Becky Quick, @BeckyQuick Joe Kernen, @JoeSquawk Katie Kramer, @Kramer_Katie